Examkin

Soru

Zorluk: Çok zorPatient Counseling and Health Education

A 55-year-old woman presents to the clinic for a follow-up visit. Three months ago, she was diagnosed with an unprovoked pulmonary embolism and was started on rivaroxaban. One month ago, she experienced an episode of melena and was diagnosed with a small gastric ulcer, which is currently healing well on a daily proton pump inhibitor. Today, the patient appears anxious. She states, "I read online that these blood thinners can cause fatal stomach bleeding. I want to stop the rivaroxaban immediately and just take a daily aspirin instead. To help manage my anxiety naturally, I recently started taking a daily St. John's wort supplement." The patient's vital signs and physical examination are unremarkable. Which of the following is the most appropriate initial counseling statement by the physician?

  1. I understand your concerns about bleeding, but stopping your anticoagulant significantly increases your risk for another blood clot; additionally, St. John's wort can reduce the effectiveness of your current blood thinner.Cevap
  2. B
    We can maintain your current medication regimen, but we must monitor you closely for bruising, as St. John's wort inhibits liver enzymes and can increase the concentration of your blood thinner.
  3. C
    If you prefer to stop the anticoagulant, taking a daily aspirin is a medically equivalent alternative for preventing another blood clot, provided you continue your stomach medication.
  4. D
    Because you are choosing to stop a life-saving medication against medical advice, I must refer you for a formal psychiatric evaluation to determine your legal competence.
  5. E
    To safely transition you off the blood thinner, we first need to refer you for your age-appropriate screening colonoscopy to confirm there are no hidden sources of bleeding in your lower intestine.

Cevap

The statement validating the patient's bleeding concerns while educating her that stopping anticoagulation increases thrombosis risk and that St. John's wort reduces the anticoagulant's efficacy.
The correct response utilizes the foundational communication skill of validating the patient's emotional concern (fear of recurrent gastrointestinal bleeding) before delivering essential medical education. It correctly identifies that discontinuing rivaroxaban prematurely—or replacing it with aspirin, which is vastly inferior for VTE prevention—places the patient at high risk for a recurrent unprovoked pulmonary embolism. Furthermore, it accurately educates the patient on a critical pharmacokinetic interaction: St. John's wort is a potent inducer of both CYP3A4 and P-glycoprotein. Coadministration increases the metabolism and efflux of rivaroxaban, thereby decreasing its serum concentration and putting the patient at an even greater risk for therapeutic failure and thrombosis.

Adım Adım Çözüm

1
Evaluate the patient's clinical status and her request to stop rivaroxaban for an unprovoked pulmonary embolism at 3 months.
Unprovoked PE typically requires at least 3 to 6 months of anticoagulation, often indefinitely. Stopping now or switching to aspirin carries a high risk of recurrent thrombosis.
Standard medical guidelines mandate DOAC therapy over aspirin for the secondary prevention of venous thromboembolism.
2
Analyze the drug-supplement interaction between rivaroxaban and St. John's wort.
St. John's wort is a strong CYP3A4 and P-glycoprotein inducer, which significantly decreases rivaroxaban plasma levels.
This pharmacokinetic interaction increases the risk of therapeutic failure and recurrent blood clots, which the patient must be educated about.
3
Formulate the most appropriate patient counseling statement based on communication best practices.
The physician must empathetically validate the patient's emotional fears (gastric bleeding), correct the misconception about aspirin equivalence, and explicitly warn her about the dangerous herbal supplement interaction.
Effective patient health education requires addressing emotional barriers while providing accurate, evidence-based medical facts.

Anahtar Kavram

Patient counseling on VTE management, drug-herb interactions (CYP3A4 inducers), and addressing medical misconceptions.
Bu soruyu puanla

Konular

Patient Counseling and Health Education

Bu konudan daha fazla soru